Editor of Patient Care Online.
Bempedoic Acid Reduces CV Risk in Latinx Population with Statin-Intolerance: Daily Dose
Your daily dose of the clinical news you may have missed.
7 Drugs Approved for Primary Care: Q1 2024
The end of another quarter means a new list of FDA-approved drugs for conditions treated in primary care. Are you up-to-date? Click through to find out.
Primary Care-Based Injury Prevention Program Found to Reduce Pediatric Injuries in New Study
The program, when implemented with support of resident training and tangible tools, reduced parent-reported injuries throughout the first 2 years of life.
T2D Remission via Lifestyle Intervention Reduces CVD, CKD Risk: Daily Dose
FDA Clears First AI-Based Algorithm to Detect Heart Failure during Routine Exams
The Low EF AI is designed to detect low ejection fraction in 15 seconds during a primary care exam.
FDA Approves Fixed-Dose Macitentan/Tadalafil Tablets for PAH: Daily Dose
Vaping Associated with Increased Risk of Heart Failure, According to New Research
ACC.24: Data showed that individuals who used e-cigarettes were approximately 19% more likely to develop heart failure compared with those who had never vaped.
Sustained LDL-C Control in High-Risk Group via Remote Lipid Program: Daily Dose
Young Adults Prescribed ADHD Stimulants May Face Higher Risk of Cardiomyopathy
ACC.24: Data showed that participants with ADHD who were prescribed stimulants were 17% more likely to develop cardiomyopathy at 1 year.
Disparities in Coronary Artery Calcium Screening: Daily Dose
Influenza Vaccine Education in Emergency Departments Improves Uptake, According to New Study
Investigators found vaccine uptake of 41% among unvaccinated individuals who were part of a messaging intervention in the emergency department.
FDA Approves Aprocitentan for Treatment-Resistant HTN: Daily Dose
Blood-Based DNA Test for Colorectal Cancer: Daily Dose
Remission from Type 2 Diabetes via Lifestyle Intervention Reduces Risk for CVD, CKD
Longer duration of remission was associated with a greater reduction in CKD and CVD risk, according to a post hoc analysis of the Look AHEAD study.
COVID-19 Vaccines Reduce Risk of Cardiac, Thromboembolic Outcomes: Daily Dose
Bempedoic Acid Associated with Reduced CV Risk in Statin-Intolerant Individuals Regardless of Ethnicity
ACC.24: Data from an analysis of the CLEAR Outcomes trial showed bempedoic acid was well-tolerated and reduced CV events in Hispanic/Latinx and non-Hispanic/Latinx participants.
Self-Administered Flu Vaccine May be “Powerful Tool” in Immunization Efforts, Says Expert
Ravi Jhaveri, MD, provides an overview of AstraZeneca's FluMist Quadrivalent vaccine and discusses why it could help increase vaccination rates.
New Data Shed Light on Disparities in Coronary Artery Calcium Screening
ACC.24: Findings showed a disproportionate distribution of CAC screening that favors White, educated, affluent, English-speaking individuals.
Tapinarof Cream 1.0% Effective for Atopic Dermatitis: Daily Dose
Obesity and Venous Disease: Risk Factors and Key Diagnostic Challenges
Johnson & Johnson Submits sBLA for Approval of Guselkumab for Adults with Ulcerative Colitis
Submission based on results from the phase 3 QUASAR induction study, which showed statistically significant and clinically meaningful improvements in symptoms.
COVID-19 Vaccines Reduce Risk of Cardiac, Thromboembolic Outcomes for up to 1 Year, According to New Data
New research highlights another benefit of COVID-19 vaccination, reported researchers.
Stroke Risk Mitigated by Low Levels of Exercise: Daily Dose
Aspirin Use among Older Adults: Daily Dose
Topline Phase 3 Data Released for Elinzanetant Efficacy for Moderate-to-Severe VMS
The novel dual NK-1,3 receptor antagonist demonstrated statistically significant reduction in the frequency of moderate-to-severe VMS vs placebo.
Underrepresentation of Patients with CKD in CVD Medication Trials: Daily Dose
Obesity and Venous Disease: An Expert Discussion
Shagun Bindlish, MD, board member of the American Diabetes Association, discusses a recent clinical practice statement she coauthored published in the journal Obesity Pillars.
Nirsevimab Effective Against RSV Hospitalization among Infants: Daily Dose
Dyslipidemia in American Indian Youth: Daily Dose
Plastic Debris in Carotid Plaque Linked to CV Events: Daily Dose
